Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06242847 · ClinicalTrials.gov registry record
Role of Insulin Action in Psoriasis Pathogenesis
A clinical trial, sponsored by Columbia University.
- Terminated
- Registry status
- 10
- Enrollment target
NCT06242847 is a clinical trial that was terminated before completion, run by Columbia University. The registered enrollment target is 10 participants.
The verdict
NCT06242847 was terminated before completion, sponsored by Columbia University.
- TERMINATED
- Registry status
- 10 participants
- Enrollment target
Study Summary
The goal of this study is to collect more information from people with plaque psoriasis and to determine if insulin plays a role in the pathogenesis of psoriasis. The main question it aims to answer is if insulin action is preserved or even enhanced in psoriatic lesions despite insulin resistance elsewhere. Participants with plaque psoriasis will have punch biopsies taken of lesional and non-lesional skin after an overnight fast and then during an oral glucose tolerance test. Biopsy specimens will then be assessed for markers of insulin action.
Interventions
- PROCEDURE Skin punch biopsy
- DIAGNOSTIC_TEST Oral glucose tolerance test (OGTT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2024-02-02 |
| Est. Completion | 2025-11-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06242847
The ClinicalTrials.gov registry entry for NCT06242847 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Skin punch biopsy is the first listed.
NCT06242847 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06242847 about?
NCT06242847 is a clinical study titled "Role of Insulin Action in Psoriasis Pathogenesis". The goal of this study is to collect more information from people with plaque psoriasis and to determine if insulin plays a role in the pathogenesis of psoriasis. The main question it aims to answer is if insulin action is preserved or even enhanced in psoriatic lesions despite insulin resistance el...
What is the current status of trial NCT06242847?
This trial is currently terminated. The enrollment target is 10 participants. The study started on 2024-02-02. Estimated completion is 2025-11-12.
What interventions are being tested in trial NCT06242847?
The interventions under investigation include: Skin punch biopsy (PROCEDURE), Oral glucose tolerance test (OGTT) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06242847?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.